Literature DB >> 8586291

Dehydroepiandrosterone sulfate in a long-term care aged population.

S Legrain1, C Berr, N Frenoy, V Gourlet, B Debuire, E E Baulieu.   

Abstract

Ninety-four institutionalized subjects (mean age 82.9 years; 13 men and 81 women) were assessed for serum dehydroepiandrosterone sulfate (DHEAS) levels. The mean value was 457 ng/ml (SD = 426) in this cross-sectional study. There was a significant decrease in DHEAS levels with age. There was no difference among demented patients with Alzheimer's disease (n = 46), other dementia cases (n = 16), and other individuals (n = 32). The subjects treated for arterial hypertension had significantly lower DHEAS levels. No correlation was found between DHEAS and cortisol values. After age adjustment, no association was observed between DHEAS and chronic diseases, medications, several biochemical or hematological parameters, or 3-year mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586291     DOI: 10.1159/000213706

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  8 in total

1.  DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Chrisandra Shufelt; Philip Bretsky; Cristina M Almeida; B Delia Johnson; Leslee J Shaw; Ricardo Azziz; Glenn D Braunstein; Carl J Pepine; Vera Bittner; Diane A Vido; Frank Z Stanczyk; C Noel Bairey Merz
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

2.  Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study.

Authors:  C Berr; S Lafont; B Debuire; J F Dartigues; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 3.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women.

Authors:  Monik C Jiménez; Qi Sun; Markus Schürks; Stephanie Chiuve; Frank B Hu; Joann E Manson; Kathryn M Rexrode
Journal:  Stroke       Date:  2013-05-23       Impact factor: 7.914

Review 5.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

Review 6.  Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Ting-Ting Wu; Yuan Chen; Yun Zhou; Dilare Adi; Ying-Ying Zheng; Fen Liu; Yi-Tong Ma; Xiang Xie
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

7.  Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer's Disease Pathology, and Cognitive Decline.

Authors:  Sami Ouanes; Christopher Clark; Jonas Richiardi; Bénédicte Maréchal; Piotr Lewczuk; Johannes Kornhuber; Clemens Kirschbaum; Julius Popp
Journal:  Front Aging Neurosci       Date:  2022-07-07       Impact factor: 5.702

8.  From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset.

Authors:  Emanuelle Nunes-Souza; Mônica Evelise Silveira; Monalisa Castilho Mendes; Seigo Nagashima; Caroline Busatta Vaz de Paula; Guilherme Guilherme Vieira Cavalcante da Silva; Giovanna Silva Barbosa; Julia Belgrowicz Martins; Lúcia de Noronha; Luana Lenzi; José Renato Sales Barbosa; Rayssa Danilow Fachin Donin; Juliana Ferreira de Moura; Gislaine Custódio; Cleber Machado-Souza; Enzo Lalli; Bonald Cavalcante de Figueiredo
Journal:  Endocr Connect       Date:  2020-12       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.